Skip to main content
Industry News
Researchers develop non-fibrillating human glycoinsulin

Researchers from the University of Melbourne developed a new non-fibrillating form of human insulin called glycoinsulin that could prevent the formation of fibrils -- or clumps of insulin -- even at high temperature and concentration, and was said to be more stable in human serum than native insulin. Detailed in the Journal of the American Chemical Society, glycoinsulin could improve the shelf life of insulin products and significantly minimize the costs and medical waste of insulin pump infusion sets.

Full Story: